Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammatory Bowel Disease I: Introduction

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

Inflammatory Bowel Disease II: Ulcerative Colitis

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Fungal abundance across flare and remission in ulcerative colitis patients.

Gut pathogens·2026

Same author

Fecal microbiome of patients with ulcerative colitis reflects their phenotype and inflammatory level.

Scientific reports·2026

Same author

International consensus statement on microbiome testing in clinical practice.

The lancet. Gastroenterology & hepatology·2024

Same author

Gut dysbiosis mediates the association between antibiotic exposure and chronic disease.

Frontiers in medicine·2024

Same author

Immunomolecular and reactivity landscapes of gut IgA subclasses in homeostasis and inflammatory bowel disease.

The Journal of experimental medicine·2024

Same author

World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics.

Journal of clinical gastroenterology·2024

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Prebiotics in inflammatory bowel diseases.

Francisco Guarner¹

¹Digestive System Research Unit Ciberehd University Hospital Vall d'Hebron Passeig Vall d'Hebron, 119-129 08035 Barcelona, Spain. fguarner@vhebron.net

The British Journal of Nutrition

|November 21, 2007

Summary

Prebiotics like inulin and oligofructose may help manage inflammatory bowel disease (IBD). These compounds promote beneficial gut bacteria, potentially reducing intestinal inflammation in conditions like Crohn's disease and ulcerative colitis.

More Related Videos

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes

Published on: February 5, 2021

Related Experiment Videos

Last Updated: Jul 11, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes

Published on: February 5, 2021

Area of Science:

Gastroenterology and Immunology
Microbiome Research
Nutritional Science

Background:

Inflammatory bowel disease (IBD) pathogenesis involves altered mucosal immune responses to gut commensal bacteria in susceptible individuals.
Dysfunctional host-microbe interactions and altered gut microbial composition are observed in Crohn's disease and ulcerative colitis.
Prebiotics are selectively fermented by gut bacteria, influencing the gut ecosystem.

Purpose of the Study:

To evaluate the potential of prebiotics, specifically inulin and oligofructose, in mitigating intestinal inflammation.
To explore the mechanisms by which prebiotics modulate the gut microbiome and immune response in IBD.

Main Methods:

Review of experimental and human studies on inulin and oligofructose.
Analysis of prebiotic effects on saccharolysis, bacterial growth (Lactobacilli, Bifidobacteria), and mucosal inflammation.
Assessment of clinical trial data for IBD and pouchitis.

Main Results:

Inulin and oligofructose stimulate colonic fermentation and promote the growth of beneficial bacteria.
These prebiotics have demonstrated reduced mucosal inflammation in animal models of IBD.
Preliminary clinical trials show encouraging results for preventing or mitigating intestinal inflammatory lesions.

Conclusions:

Inulin and oligofructose show promise as a strategy to prevent or reduce intestinal inflammation in IBD.
Prebiotic intervention represents a potential therapeutic avenue for managing Crohn's disease, ulcerative colitis, and pouchitis.
Further clinical research is warranted to confirm efficacy and optimal use in human IBD.